Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice

Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice

The speed at which several COVID-19 vaccines went from conception to receiving FDA and EMA approval for emergency use is an achievement unrivaled in the history of vaccine development. Mass vaccination efforts using the highly effective vaccines are currently underway to generate sufficient herd imm...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chih-Yun Lai, Albert To, Teri Ann S. Wong, Michael M. Lieberman, David E. Clements, James T. Senda, Aquena H. Ball, Laurent Pessaint, Hanne Andersen, Wakako Furuyama, Andrea Marzi, Oreola Donini, Axel T. Lehrer
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
SARS-CoV-2 vaccine
Spike glycoprotein
Recombinant protein
Adjuvant
CoVaccine HT™
Immunologic diseases. Allergy
RC581-607
Acceso en línea:https://doaj.org/article/4899da1012804294873b875b8874ede5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/4899da1012804294873b875b8874ede5

Ejemplares similares